Imago BioSciences
San Carlos
About Imago BioSciences
Imago BioSciences is a clinical development company dedicated to translating state-of-the art science into novel medicines for treating diseases that currently pose great challenges to patients, their families and their physicians. The company leverages the skills and extensive experience of its team and the financial commitment of its investors to focus on a small family of orphan diseases. Imago BioSciences translates unique insights into high impact transformative therapies that alter the natural history of disease allowing patients to live longer, disease-free lives. Imago BioSciences was founded in 2012 and is based in Redwood City, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $146.5M
- Funding stage: M&A
- Last round: Series C (Nov 2020)
- Ticker: nasdaq:IMGO
- Website: imagobio.com
- Phone: (415) 529-5055
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/imago-biosciences-99092 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.